Cancer Letters
Издатель: Elsevier · ISSN 0304-3835 · 51 статей
- Epithelial FOXP3: The Silent Spark That Lights the Fire of Pancreatic Cancer
- Polyploid giant cancer cells: A hidden cost of Aurora Kinase inhibitors and antimitotic therapies revealed through the PGCC Explorer
- LINC00941 Drives Chemoresistance via Modulating PKM2 Activity and Aerobic Glycolysis in Oral Squamous Cell Carcinoma
- Myeloid-derived suppressor cells in the tumor microenvironment: cellular crosstalk, immunosuppressive effects, and therapeutic targets.
- Visualizing and Targeting Tumor-Associated Neutrophils: Advanced Imaging, Therapeutic Reprogramming, and Cell-Based Delivery for Precision Oncology
- Multidimensional Regulation of Metal Ions in the Tumor Microenvironment and Innovative Strategies for Diagnosis and Therapy
- CENPT Promotes Pancreatic Cancer Progression by Activating the RAF/MEK/ERK Signaling Pathway and Triggering MIF-Mediated Immunosuppression
- Early transcriptional divergence and spatial remodeling toward immune activation and evasion shape lung adenocarcinoma precancer evolution
- Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning
- Acquisition of therapeutic resistance and structured tissue differentiation via activation of the life cycle of polyploid giant cancer cells
- Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]
- Progress in incidence, mortality, survival, and premature mortality of hepatobiliary cancer overall and by subtype in China 2010–2024: a population-based study
- The metabolic dependency on GLUT3 mediates smoking-induced NSCLC progression
- Tumor-nervous system crosstalk in PDAC: Current landscape, challenges, and future directions
- Effective Targeting of p53-Mutant Colorectal and Pancreatic Cancers by Combinatorial Therapeutic Strategy
- Early-onset Pancreatic Neuroendocrine Tumors: Distinct and Age-Related Metabolic Profiles
- Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice
- TAT-Cx43266-283 limits recurrence-associated features and improves survival after tumor resection in preclinical glioblastoma models
- CIP2A drives lung adenocarcinoma by activating mitochondrial respiratory complexes IV and V
- Quercetin suppresses radial glial stem-like cell functions through an HSPB1-associated mechanism in glioma
- Targeting the CCL5–CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming
- TAM-derived CCL7 Drives CRC Progression and Chemoresistance by Reprogramming Lipid Metabolism via the BATF3/USP22/DGAT2 Axis
- Restoring Activation-Linked Clusterin Loss Attenuates Tumor-Directed T Cell Dysfunction Associated with Reduced Translation and Proteostatic Stress
- Amplification of ABCB1-harboring extrachromosomal amplicons endows gallbladder cancer with bortezomib resistance
- The RAS revolution in gastrointestinal cancers: Where we are and where we go next
- A Spatial Multi-omics Atlas of Intra- and Extrapancreatic Perineural Invasion Reveals Basal-like Neurotropism and Stromal Remodeling in Pancreatic Cancer
- TAGLN2 Drives Glioma Immune Evasion by Coordinating Macrophage Recruitment and Exosome-Mediated Functional Remodeling
- FAP-Targeted Molecular Imaging of CAFs-Mediated Chemoresistance and Reversal by JAK/STAT Inhibition in Gastric Cancer
- Chronic stress drives gastric cancer cachexia via cGAS-STING/NLRP3 signaling through a feedforward CGRP-NGF axis-mediated NETosis
- TGF-β-induced CD101 expression on CD8 T cells regulates anticancer responses